ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT
ARS Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 112.34M | 97.12M | 89.15M | 2.57M | 500K | 10K | 30K | -1.29M | -1.1M | -643K | n/a | 2.07M | 2.41M | 4.06M | 5.51M | 4.75M | 4.22M | 2.11M |
Cost of Revenue | 2.07M | 2.09M | 1.01M | 153K | 62K | 7.35M | 13.89M | 17.54M | 17.83M | 14.87M | 13.74M | 10.52M | 10.74M | 6.89M | 1.93M | 1.96M | 1.83M | 1.74M |
Gross Profit | 94.55M | 95.05M | 88.16M | 2.43M | 456K | -7.34M | -13.86M | -18.82M | -18.93M | -15.52M | -13.74M | -8.45M | -8.34M | -2.83M | 3.58M | 2.79M | 2.4M | 377K |
Operating Income | -59.34M | -27.07M | -3.08M | -60.51M | -56.74M | -62M | -67.52M | -72.74M | -61.39M | -47.13M | -35.52M | -43.58M | -59.63M | -77.8M | -89.58M | -79.18M | -62.96M | -43.69M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 600K | 1.68M | 1.68M | 1.68M | 1.88M | 800K | 800K | 800K | 16K | 16K | 16K |
Pretax Income | -47.73M | -15.36M | 8.29M | -49.1M | -44.82M | -49.68M | -54.35M | -61.61M | -53.34M | -42.39M | -34.68M | -43.71M | -59.78M | -77.86M | -89.48M | -79.1M | -62.91M | -43.7M |
Net Income | -48.02M | -15.65M | 8M | -49.1M | -44.82M | -49.68M | -50.59M | -57.85M | -49.59M | -38.27M | -34.46M | -43.49M | -59.57M | -78.01M | -89.48M | -79.1M | -62.91M | -43.7M |
Selling & General & Admin | 150.19M | 104.82M | 71.67M | 43.01M | 38.7M | 43.06M | 47.28M | 51.2M | 39.15M | 28.3M | 18.46M | 15.12M | 18.89M | 22.91M | 26.94M | 23.53M | 17.9M | 11.99M |
Research & Development | 14.44M | 17.3M | 19.58M | 19.96M | 18.54M | 18.95M | 20.27M | 21.57M | 22.46M | 19.5M | 18.38M | 29.35M | 40.9M | 54.09M | 60.72M | 53.68M | 43.23M | 29.96M |
Other Expenses | 4.98M | n/a | n/a | n/a | n/a | 3.23M | 6.99M | 8.14M | 8.19M | 4.88M | 974K | -180K | -227K | -151K | n/a | n/a | n/a | n/a |
Operating Expenses | 169.61M | 122.12M | 91.25M | 62.96M | 57.24M | 62.01M | 67.55M | 72.77M | 61.61M | 47.8M | 36.83M | 44.47M | 59.79M | 77M | 87.66M | 77.21M | 61.13M | 41.96M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 218K | 218K | 218K | 369K | 151K | 151K | 151K | n/a | n/a | 4K | 41K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.59M | 11.27M | 16.82M | 22.25M | 16.66M | 10.98M | 5.43M |
Cost & Expenses | 108.35M | 124.19M | 92.23M | 63.07M | 57.24M | 62.01M | 67.55M | 72.77M | 61.61M | 47.8M | 36.83M | 44.9M | 60.76M | 78.46M | 89.58M | 79.18M | 62.96M | 43.69M |
Income Tax Expense | 288K | 288K | 255.72K | -32.28K | -32.28K | -52.28K | -3.77M | -3.77M | -3.79M | -4.14M | -238.08K | -238.08K | -218K | 151K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
Shares Outstanding (Diluted) | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
EPS (Basic) | -0.5 | -0.17 | 0.07 | -0.51 | -0.47 | -0.52 | -0.53 | -0.61 | -0.52 | -0.4 | -0.36 | -0.88 | -1.46 | -2.1 | -2.56 | -2.27 | -1.81 | -1.27 |
EPS (Diluted) | -0.5 | -0.17 | 0.07 | -0.51 | -0.47 | -0.52 | -0.53 | -0.61 | -0.52 | -0.4 | -0.36 | -0.88 | -1.46 | -2.1 | -2.56 | -2.27 | -1.81 | -1.27 |
EBITDA | -57.66M | -25.37M | -3.05M | -60.47M | -56.67M | -61.95M | -67.49M | -72.42M | -61.08M | -46.82M | -35.15M | -43.04M | -58.53M | -76.2M | -87.55M | -77.16M | -61.1M | -41.94M |
EBIT | -11.73M | -27.07M | -3.08M | -60.51M | -56.74M | -62M | -67.52M | -72.74M | -61.39M | -47.13M | -35.52M | -43.53M | -59.56M | -77.71M | -89.48M | -79.1M | -62.91M | -43.66M |
Depreciation & Amortization | 1.67M | 1.69M | 21K | 62K | 62K | 64K | 73K | 360K | 656K | 1.12M | 1.56M | 1.69M | 1.92M | 1.92M | 1.93M | 1.96M | 1.83M | 1.74M |